Physician profile
Amanda Shaw
NPI 1619498698
$638.82
in general payments reported to CMS, 2019-2025
9 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $377 · 2021: $37.79 · 2022: $37.05 · 2024: $74.41 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $382.15 | 2020-2025 | Ozempic |
| Pfizer INC. | $73.55 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.71 | 2021-2025 | Xifaxan |
| Abbvie INC. | $48.06 | 2022-2025 | |
| Axsome Therapeutics, INC. | $23.29 | 2025 | Sunosi |
| E.R. Squibb & Sons, L.L.C. | $17.20 | 2022 | |
| Amgen INC. | $15.21 | 2025 | Repatha, Otezla |
| Currax Pharmaceuticals LLC | $14.07 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $12.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.